# Orbactiv

NDC: 70842-140
Generic name: oritavancin
Labeler / Manufacturer: Melinta Therapeutics, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20140901

FDA application: NDA206334

## Active ingredients

- ORITAVANCIN: 400 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70842-140"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70842-140
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ff09a726-9f9b-4e30-b509-396781293220